Pricing Log in Create free account

Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Champions Oncology, Inc. (CSBR)

Corbus Pharmaceuticals Holdings, Inc. and Champions Oncology, Inc. are both Biotechnology companies. Champions Oncology, Inc. is the larger, with a market value of $66.3M against $55.3M — 1.2× the size. Champions Oncology, Inc. grew revenue faster over the last twelve months: 6.65% against −73.7%. Corbus Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (0.00% vs −626.2%). Across the 18 metrics below, Corbus Pharmaceuticals Holdings, Inc. leads on 9 and Champions Oncology, Inc. on 9.

Valuation

Metric CRBP CSBR Biotechnology median
P/E n/m n/m 10.26
P/S 36.05 1.10 9.18
P/B 0.54 14.93 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.37 200.35 0.65
EV/Sales (26.17) 1.03 8.98
Earnings yield (216.43%) (1.67%) (34.89%)
Free cash flow yield (156.18%) (9.18%) (24.52%)

Profitability

Metric CRBP CSBR Biotechnology median
Gross margin 0.00% 49.82% 65.16%
Operating margin 0.00% (1.68%) 0.00%
Net margin 0.00% (1.87%) 0.00%
Free cash flow margin 0.00% (10.08%) 0.00%
Return on equity (95.58%) (28.38%) (50.12%)
Return on assets (80.85%) (3.56%) (45.60%)
Return on invested capital 0.00% (626.23%) 0.00%

Growth

Metric CRBP CSBR Biotechnology median
Revenue growth (TTM) (73.69%) 6.65% 6.26%
EPS growth (last fiscal year) (60.33%) (124.24%) 29.88%
Revenue growth, 5-year CAGR (14.34%) 7.68% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP CSBR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 1.03 4.89
Net debt to EBITDA 1.90 (20.56) 1.01

Dividend

Metric CRBP CSBR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBP CSBR Biotechnology median
Market cap 55.32m 66.26m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack